Laser-Assisted Subepithelial Keratectomy (LASEK)
No Results
No Results
processing….
Laser-assisted subepithelial keratectomy (LASEK) is a laser surgical procedure for the correction of refractive error. LASEK is specifically used to correct astigmatism, hyperopia (farsightedness), and myopia (nearsightedness). It is a “hybrid” technique between laser assisted in situ keratomileusis (LASIK) and photorefractive keratectomy (PRK). The LASEK technique attempts to decrease the occurrence of flap-related complications associated with LASIK and, as in PRK, is specifically helpful in patients with corneas that are otherwise too thin for LASIK. By retaining a flap of corneal epithelium, LASEK may decrease the risk of infection and incidence of corneal haze, while reducing recovery time and postoperative discomfort when compared with PRK.
Concepts of corneal refractive surgery, such as keratectomy, keratotomy, and thermokeratoplasty, were first described in 1898 by Lans who published a set of experiments that focused on treating astigmatism in rabbits.
Refractive surgery, as it is known today, was not realized until 1966 when Pureskin first appreciated its potential with the demonstration that refractive changes could be made by removing central tissue underneath a corneal flap. Barraquer later showed that the corneal disc could be resected and frozen so that it could be reshaped using a cryolathe. However, his technique used complex equipment and had high intraoperative and postoperative complication rates, and the freezing resulted in damage to the disc itself.
In the late 1980s, Ruiz and Barraquer performed the first published keratomileusis in situ. They followed principles formulated by Krumeich using a microkeratome to remove a portion of the cornea followed by a second plano cut, the thickness and diameter of which established refractive change. The first disc was then repositioned and sutured back onto the cornea. These initial attempts were complex and unpredictable, often leading to keratoconus and other irregular astigmatisms.
Burratto and Pallikaris then combined the microkeratome technique with the use of the excimer laser to ablate tissue and to induce refractive change. Buratto performed excimer laser ablation on the posterior surface of the resected corneal disc before replacing and resuturing it back to its original position. Pallikaris then used the excimer laser ablation on the corneal stromal bed under a hinged flap in rabbit corneas. Pallikaris attempted this technique on blind human eyes in 1989 and on sighted human eyes in 1991, thereby creating a refractive surgical technique similar to the procedures currently in practice.
In 1993, Slade developed an automated microkeratome to refine the creation of the flap. Slade was one of the first surgeons to perform LASIK in the United States.
Since its introduction, LASIK has been associated with various complications, specifically when performed on eyes with decreased corneal thickness, irregular astigmatism, dryness, preexisting ocular surface disease, or glaucoma, to the point where several of these entities have become relative contraindications to performing LASIK. For these reasons, LASEK was developed to reduce the chance of complications that occur secondary to LASIK while inducing less discomfort than PRK.
Italian ophthalmologist Camellin is credited with developing the original LASEK procedure when he described the Camellin technique in ophthalmic literature in 1999. This technique involved the use of alcohol to separate the corneal epithelium from the stroma to create an epithelial sheet that could be repositioned over the ablated stroma. Since then, this method has evolved into multiple techniques, including Butterfly LASEK developed by Vinciguerra and Camesasca in 2002, cruciform LASEK described by Amolis in 2002, and gel-assisted LASEK created by McDonald in 2004. [1] Each of these techniques is described in Intraoperative details.
Ocular refraction is defined as the ability of the eye to bend light rays to focus them on the retina. The cornea, the lens, and the axial length of the eye are the main contributors to the eye’s refraction capability. The total refractive power of an emmetropic (or normal length) eye is approximately 58 diopters (D), of which 43 D come from the cornea and the remaining 15 D from the lens, aqueous, and vitreous. Astigmatism, myopia (nearsightedness), and hyperopia (farsightedness) are common forms of refractive error that cause irregularities of the bending of light rays, thereby leading to blurred or distorted vision.
Myopia (nearsightedness) is a condition in which the eye is too long or the refractive power is too great, causing objects to focus at a point before the retina rather than upon the retina itself (see the image below).
This inability to focus appropriately leads to an inability to see distant objects clearly. This problem tends to first appear in school-aged children and may progress through adolescence but usually stabilizes in early adulthood.
In hyperopia (farsightedness), the eye is too short or the refractive error is too weak because the cornea is too flat (see the image below).
This irregularity causes an inability of the eye to bring near objects into clear focus because light entering the eye focuses behind the retina rather than directly on it. Because younger individuals may accommodate (or adjust) to focus near objects, the blurred vision associated with hyperopia is often not appreciated until later years as the eye loses this ability to accommodate.
In astigmatism, the refractive power of the eye is not the same in all meridians (see the image below).
For example, the eye may exhibit more myopia horizontally than vertically. It is usually secondary to an irregular curvature of the cornea that prevents light from properly focusing on the retina.
Astigmatism, myopia, and hyperopia are relatively common in the general population. Myopia and hyperopia have an estimated prevalence of 33% and 25%, respectively. The prevalence of astigmatism varies with the definition used as clinically significant astigmatism. As many as 75% of the population has at least minor, clinically insignificant astigmatism present in either one eye or both eyes. Specifically, in the general population, 44% have greater than 0.50 D, 10% have greater than 1 D, and 8% have greater than 1.50 D.
A refractive surgery survey conducted in 2004 regarding 2003 practices identified LASIK as the most common refractive surgical procedure, with wavefront-guided ablation as an increasingly popular entity, increasing from 13% to 60% during 2002-2003 alone. Of the more than 1000 ophthalmologists who participated in this retrospective study, 71% were found to perform PRK, and 41% were found to perform LASEK. Of those ophthalmologists who performed LASEK, more than one half only performed this procedure when LASIK was not an option.
Another survey focused on the refractive surgery practices of the United States Army Warfighter Refractive Eye Surgery Program (WRESP) during 2000-2003. Of the more than 16,000 patients over these 4 years, nearly three quarters of cases involved surface ablative procedures, namely PRK or LASEK. PRK was performed on 64.7% of eyes, LASEK was performed on 8.7% of eyes, and LASIK procedures were performed on the remaining 26.6% of eyes.
The major indications for refractive surgery include astigmatism, myopia, and hyperopia, specifically in patients who are intolerant of or who desire to be free from glasses or contact lenses. Typically, up to 10 D of myopia and 4 D of hyperopia are the limits of corneal refractive surgery, but the US Food and Drug Administration (FDA) has approved treatment of as much as 14 D of myopia, 6 D of hyperopia, and 6 D of cylinder.
Since the popularization of laser-assisted in situ keratomileusis (LASIK), surface ablative procedures, such as photorefractive keratectomy (PRK) and laser-assisted subepithelial keratectomy (LASEK), have usually been confined to individuals in whom LASIK is not recommended. However, due to the potential structural and other advantages of surface procedures, there are now many ophthalmologists who suggest surface procedures over LASIK, or who will endorse both equally. The characteristics that may prompt an ophthalmologist to recommend surface ablation over LASIK include the following:
Thin corneal pachymetry
Steep or flat corneas
Wide scotopic pupil (controversial)
LASIK complications in fellow eye
Predisposition to trauma
Irregular astigmatism
Glaucoma suspects
Recurrent erosion syndrome
Epithelial basement membrane disease
Corneal scars
Persistent epithelial infiltrates (typically related to soft contact lens wear or prior viral conjunctivitis)
Highly irregular astigmatism, specifically keratoconus, as well as severe dry eye syndrome can serve as contraindications to LASEK as well as to LASIK.
The cornea accounts for two thirds of the refractive power that acts to focus light rays on the back of the eye. Of this, approximately 80% of the refractive power is created by the air-tear interface. Average cornea diameter is approximately 11 mm vertically and 12 mm horizontally.
The cornea consists of 5 layers. From superficial to deep, these layers are the corneal epithelium, Bowman’s layer, the stroma, the Descemet membrane, and the endothelium.
The corneal epithelium consists of 5-7 layers of stratified squamous epithelium. Defects in this layer may cause severe pain secondary to the rich sensory innervation. Fortunately, damage to the epithelium is quickly repaired in healthy eyes. The Bowman layer, on the other hand, is not replaced after injury, and this tough layer of collagen fibers may become opacified and replaced by scar tissue after trauma. The stroma makes up about 500 µm (90%) of the average 550-µm central corneal thickness. Its 200-250 lamellae (flattened bundles of collagen) give the cornea its clarity, strength, and shape. The lamellae are produced by scattered stromal fibroblasts or keratocytes. Keratocytes are also responsible for wound healing if the cornea becomes damaged.
The Descemet membrane serves as the acellular basement membrane of the corneal endothelium. Like the Bowman layer, it is not replaced after injury and may result in scar formation. The deepest layer of the cornea is a monolayer of endothelial cells whose primary function is the maintenance of corneal fluid balance, thereby maintaining clarity across the cornea. Unlike the epithelium, these cells rarely undergo mitosis and instead decrease in number with age. See the images below for illustration of the layers of the cornea and corneal topography.
Contraindications common to laser assisted in situ keratomileusis (LASIK), laser assisted subepithelial keratectomy (LASEK), and photorefractive keratectomy (PRK) include the following:
Unstable refractive error
Refractive error outside the range of correction (The range varies according to the surgeon’s experience, the laser used, and the laser strategy; however, it is typically approximately 9-14 D of myopia, 4-6 D of hyperopia, and 2-6 D of astigmatism.)
Keratoconus or forme fruste keratoconus
Pellucid marginal degeneration
Significant dry eye syndrome
Active inflammation of external eye
Autoimmune disease
History of or active herpes simplex keratitis, because of the concern of eliciting reactivation of the virus
Active collagen vascular disease
Uncontrolled diabetes
Uncontrolled glaucoma
Pregnancy or breastfeeding
Use of medications that may adversely affect corneal wound healing, such as Accutane (isotretinoin), Cordarone (amiodarone hydrochloride), and Imitrex (sumatriptan)
Presence of a pacemaker
Contraindications unique to LASEK and PRK include the following:
Concern regarding postoperative pain
Requirement of rapid visual recovery
Unlike LASIK, patients with thin, flat, or steep corneas may still be candidates for LASEK and PRK.
Scerrati E. Laser in situ keratomileusis vs. laser epithelial keratomileusis (LASIK vs. LASEK). J Refract Surg. 2001 Mar-Apr. 17(2 Suppl):S219-21. [Medline].
Wolf A, Abdallat W, Kollias A, Frohlich SJ, Grueterich M, Lackerbauer CA. Mild topographic abnormalities that become more suspicious on Scheimpflug imaging. Eur J Ophthalmol. 2009 Jan-Feb. 19(1):10-7. [Medline].
Li Y1, Tan O, Brass R, Weiss JL, Huang D. Corneal epithelial thickness mapping by Fourier-domain optical coherence tomography in normal and keratoconic eyes. Ophthalmology. Dec 2012. 119 (12):2425-33. [Full Text].
Schmidt GW, Yoon M, McGwin G, Lee PP, McLeod SD. Evaluation of the relationship between ablation diameter, pupil size, and visual function with vision-specific quality-of-life measures after laser in situ keratomileusis. Arch Ophthalmol. 2007 Aug. 125(8):1037-42. [Medline].
Camellin M, Wyler D. Epi-LASIK versus epi-LASEK. J Refract Surg. 2008 Jan. 24(1):S57-63. [Medline].
Hammond MD, Madigan WP Jr, Bower KS. Refractive surgery in the United States Army, 2000-2003. Ophthalmology. 2005 Feb. 112(2):184-90. [Medline].
Zhao LQ, Wei RL, Cheng JW, Li Y, Cai JP, Ma XY. Meta-analysis: clinical outcomes of laser-assisted subepithelial keratectomy and photorefractive keratectomy in myopia. Ophthalmology. 2010 Oct. 117(10):1912-22. [Medline].
Adams GW, Hubbard AD. Kennerley Bankes Clinical Ophthalmology: A Text and Color Atlas. 4th ed. 1999.
[Guideline] American Academy of Ophthalmology Refractive Management/Intervention Panel. Refractive errors & refractive surgery. San Francisco (CA): American Academy of Ophthalmology; 2007. [Full Text].
Aydin B, Cagil N, Erdogan S, Erdurmus M, Hasiripi H. Effectiveness of laser-assisted subepithelial keratectomy without mitomycin-C for the treatment of high myopia. J Cataract Refract Surg. 2008 Aug. 34(8):1280-7. [Medline].
Brown MC, Schallhorn SC, Hettinger KA, Malady SE. Satisfaction of 13,655 patients with laser vision correction at 1 month after surgery. J Refract Surg. 2009 Jul. 25(7 Suppl):S642-6. [Medline].
Chen KH, Hsu WM, Lee SM, Lai JY, Li YS. Laser-assisted subepithelial keratectomy for dry eye associated with soft contact lenses. J Cataract Refract Surg. 2005 Dec. 31(12):2299-305. [Medline].
Cleveland Clinic Foundation Health Information Center. LASEK: Overview. 2006. [Full Text].
Gimbel HV, Penno EEA. Trends and Techniques. LASIK Complications. 3E. 184-90.
Horwath-Winter J, Vidic B, Schwantzer G, Schmut O. Early changes in corneal sensation, ocular surface integrity, and tear-film function after laser-assisted subepithelial keratectomy. J Cataract Refract Surg. 2004 Nov. 30(11):2316-21. [Medline].
Kanski, Menon, Boulton. A Systematic Approach. Clinical Ophthalmology. 5th ed. 2003. 56-63.
Laplace O, Bourcier T, Chaumeil C, Cardine S, Nordmann JP. Early bacterial keratitis after laser-assisted subepithelial keratectomy. J Cataract Refract Surg. 2004 Dec. 30(12):2638-40. [Medline].
Lee HK, Lee KS, Kim JK, Kim HC, Seo KR, Kim EK. Epithelial healing and clinical outcomes in excimer laser photorefractive surgery following three epithelial removal techniques: mechanical, alcohol, and excimer laser. Am J Ophthalmol. 2005 Jan. 139(1):56-63. [Medline].
Samalonis LB. LASEK techniques. EyeWorld. 2002. 7(9):31-32.
Sandoval HP, de Castro LE, Vroman DT, Solomon KD. Refractive Surgery Survey 2004. J Cataract Refract Surg. 2005 Jan. 31(1):221-33. [Medline].
Taneri S, Zieske JD, Azar DT. Evolution, techniques, clinical outcomes, and pathophysiology of LASEK: review of the literature. Surv Ophthalmol. 2004 Nov-Dec. 49(6):576-602. [Medline].
Vinciguerra P, Camesasca FI, Torres IM. Transition zone design and smoothing in custom laser-assisted subepithelial keratectomy. J Cataract Refract Surg. 2005 Jan. 31(1):39-47. [Medline].
Li SM, Zhan S, Li SY, Peng XX, Hu J, Law HA, et al. Laser-assisted subepithelial keratectomy (LASEK) versus photorefractive keratectomy (PRK) for correction of myopia. Cochrane Database Syst Rev. 2016 Feb 22. 2:CD009799. [Medline].
Brad Feldman, MD Cornea, Cataract, and Refractive Surgeon, Philadelphia Eye Associates
Brad Feldman, MD is a member of the following medical societies: American Academy of Ophthalmology, American Society of Cataract and Refractive Surgery, Association for Research in Vision and Ophthalmology
Disclosure: Nothing to disclose.
Reecha Sachdeva, MD Resident Physician, Cole Eye Institute, Cleveland Clinic
Reecha Sachdeva, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Ophthalmology, American Medical Student Association/Foundation
Disclosure: Nothing to disclose.
Sanjeev Grewal, MD, FRCSC Associate Professor of Ophthalmology, Chief, Cornea and Refractive Surgery, Residency Program Director, Department of Ophthalmology, Medical Faculty Associates, George Washington University
Sanjeev Grewal, MD, FRCSC is a member of the following medical societies: American Academy of Ophthalmology, Association for Research in Vision and Ophthalmology, College of Physicians and Surgeons of Ontario, Royal College of Physicians and Surgeons of Canada
Disclosure: Nothing to disclose.
Ronald R Krueger, MD Medical Director, Department of Refractive Surgery, Division of Ophthalmology, Cole Eye Institute, Cleveland Clinic Foundation
Ronald R Krueger, MD is a member of the following medical societies: American Academy of Ophthalmology, American Medical Association, American Society of Cataract and Refractive Surgery, Association for Research in Vision and Ophthalmology, International Society of Refractive Surgery, SPIE
Disclosure: Nothing to disclose.
Simon K Law, MD, PharmD Clinical Professor of Health Sciences, Department of Ophthalmology, Jules Stein Eye Institute, University of California, Los Angeles, David Geffen School of Medicine
Simon K Law, MD, PharmD is a member of the following medical societies: American Academy of Ophthalmology, Association for Research in Vision and Ophthalmology, American Glaucoma Society
Disclosure: Nothing to disclose.
Louis E Probst, MD, MD Medical Director, TLC Laser Eye Centers
Louis E Probst, MD, MD is a member of the following medical societies: American Academy of Ophthalmology, American Society of Cataract and Refractive Surgery, International Society of Refractive Surgery
Disclosure: Nothing to disclose.
Michael Taravella, MD Director of Cornea and Refractive Surgery, Rocky Mountain Lions Eye Institute; Professor, Department of Ophthalmology, University of Colorado School of Medicine
Michael Taravella, MD is a member of the following medical societies: American Academy of Ophthalmology, American Medical Association, American Society of Cataract and Refractive Surgery, Contact Lens Association of Ophthalmologists, Eye Bank Association of America
Disclosure: J&J Vision VISX (Consultant), no income received for: Coronet Surgical (Consultant), no income received.
Daniel S Durrie, MD Director, Department of Ophthalmology, Division of Refractive Surgery, University of Kansas Medical Center
Daniel S Durrie, MD is a member of the following medical societies: American Academy of Ophthalmology, Association for Research in Vision and Ophthalmology
Disclosure: Received grant/research funds from Alcon Labs for independent contractor; Received grant/research funds from Abbott Medical Optics for independent contractor; Received ownership interest from Acufocus for consulting; Received ownership interest from WaveTec for consulting; Received grant/research funds from Topcon for independent contractor; Received grant/research funds from Avedro for independent contractor; Received grant/research funds from ReVitalVision for independent contractor.
Laser-Assisted Subepithelial Keratectomy (LASEK)
Research & References of Laser-Assisted Subepithelial Keratectomy (LASEK)|A&C Accounting And Tax Services
Source
0 Comments